Associate Director Regulatory Labeling

The Plasma-Derived Therapies (PDT) R&D Organization is dedicated to bringing forward new plasma-derived therapies for patients with immunologic, hematologic, and other complex diseases. There are two main drivers of innovation that are the focus of the PDT R&D organization:
Translational Pharmaceutical Sciences and Precision Medicine

The Global Regulatory Labeling Strategy Lead (Associate Director), Plasma-Derived Therapies Business Unit (PDT BU) is a key role in Global Labeling and works under the direction of the Head of Global Labeling and is:

Responsible, with minimal supervision for providing regulatory expertise, strategic insight, and guidance to internal stakeholders, including Clinical, Pharmacovigilance, Legal, Scientific,

Commercial, to ensure successful development and maintenance of labeling managed within

PDT BU’s Global Labeling function, pertaining to pharmaceutical drug and device.

Ensuring that there is strategic labeling input in the implementation of regulatory strategies and liaises with regulatory team members in evolving submission and negotiation plans.

Formulating regulatory labeling strategies for implementation of new and revised prescribing

information and packaging; strategically interprets scientific, medical, and regulatory data and

information.

Providing expert advice on current labeling requirements, templates, tools, and Health Author-

ity-issued guidance pertaining to pharmaceutical drug and device.

Drives labeling strategy for the PDT BU via the development and lifecycle management of the

CCDS, US, and EU labels.

Formulates and implements innovative regulatory strategies for labeling development to sup-

port successful commercialization of developmental products and enhance opportunity for mar-

keted products and global expansion.

Prepares strategic labeling vision for early development programs and gains alignment from

internal stakeholders.

Draws on labeling precedent, Health Authority feedback, and guidance, to create innovative

labeling strategies.

Provides guidance on combination product/drug-device labeling.

Interprets scientific and clinical data and leads development of labeling to optimize product potential and patient benefit-risk ratio.

Introduces creative solutions for data presentation and gains consensus by labeling teams to

meet the requirements of the Health Authorities

Prepares backup strategies in support of labeling negotiations.

Takes initiative in leading global labeling team and cross-functional projects.

Leads CCDS, US, and EU Labeling Teams in the development and maintenance of labeling.

Actively engages cross-functional labeling stakeholders to gain consensus on labeling strategy.

Effectively identifies and resolves conflicts/issues to reach labeling decisions with minimal es-

calation to management for dispute resolution.

Liaises with Regulatory Intelligence to maintain awareness of regulatory legislation pertaining

to labeling and communicates the impact on the PDT BU products.

Provides guidance to Regulatory affiliates as necessary in assessment of labeling changes to

ensure timely implementation.

In close collaboration with the Takeda R&D labeling function, oversees the direction, manage-

ment and implementation of the labeling processes, templates, tools and systems to improve efficiency, productivity and quality and consistency across products and compliance with regu-

latory labeling guidance.

Project manages new or updated labeling to ensure compliance with internal procedural or

Health Authority submission timelines.

Manages and facilitates review of CCDSs and regional labeling, as appropriate, via the Label-

ing Team and executive governance committees for PDT BU products.

Prepares final proposed labeling for…